Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Clinical Efficacy and Economic Evaluation of EC-MPS (Myfortic) in the Treatment of Relapse or Resistant Proliferative Lupus Nephritis

NCT01015456 is registered in ClinicalTrials.gov with Chulalongkorn University as lead sponsor.

NCT NCT01015456
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01015456 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Clinical Efficacy and Economic Evaluation of EC-MPS (Myfortic) in the Treatment of Relapse or Resistant Proliferative Lupus Nephritis
Lead sponsor
Chulalongkorn University
Phase
Phase 3
Overall status
Terminated
Start date
January 31, 2010
Completion date
January 31, 2013
Enrollment
59 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

lupus nephritis